)
Bertrand Magy
CEO
ATB Therapeutics
Bertrand leads the management, strategy, and execution at atbtherapeutics. He has driven the company from early concept to a robust biotechnology platform, overseeing fundraising, product and process development, and playing a key role in the evolution of the company’s governance and advisor network. He is also one of the experts contributing to the development and industrialisation of the atbiofarm technology.
Bertrand previously worked as a SpinOff Project Manager and postdoctoral researcher at the University of Louvain.
He holds a PhD in Bioengineering and an MSc in Management from the Louvain School of Management, Belgium.
Sessions
-
23-Jun-2026Theater 3ATB Tx
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}